Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.

PMID:
26322666
2.

In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial.

Clin Infect Dis. 2015 Jul 15;61(2):270-80. doi: 10.1093/cid/civ260. Epub 2015 Apr 1.

PMID:
25838291
3.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

4.

Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.

Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group.

Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12.

5.

Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S; ANRS-EPF CO1-CO11 Study Group.

Clin Infect Dis. 2013 Sep;57(6):903-14. doi: 10.1093/cid/cit374. Epub 2013 May 31.

6.

[Consequences and experiences of the transition to adult medicine for young people living with human immunodeficiency virus (HIV)].

Vaudre G, Sylvain H, Delmas P, Dollfus C, Leverger G.

Arch Pediatr. 2012 Aug;19(8):786-93. doi: 10.1016/j.arcped.2012.05.003. Epub 2012 Jun 27. French.

PMID:
22743171
7.

Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers.

Simon A, Warszawski J, Kariyawasam D, Le Chenadec J, Benhammou V, Czernichow P, Foissac F, Laborde K, Tréluyer JM, Firtion G, Layouni I, Munzer M, Bavoux F, Polak M, Blanche S; ANRS French Perinatal Cohort Study Group.

JAMA. 2011 Jul 6;306(1):70-8. doi: 10.1001/jama.2011.915.

PMID:
21730243
8.

Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy.

Briand N, Mandelbrot L, Blanche S, Tubiana R, Faye A, Dollfus C, Le Chenadec J, Benhammou V, Rouzioux C, Warszawski J; ANRS French Perinatal Cohort (ANRS EPF-CO-01).

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):126-35. doi: 10.1097/QAI.0b013e318219a3fd.

PMID:
21436712
9.

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

PENPACT-1 (PENTA 9/PACTG 390) Study Team, Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS.

Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31.

10.

[A nursing consultation to improve antiretroviral medication management in children].

Vaudre G, Dollfus C, Tabone MD, Courcoux MF, Portier E, Leverger G.

Soins Pediatr Pueric. 2010 Sep-Oct;(256):35-8. French.

PMID:
20925307
11.

[When "HIV positive children" have babies].

Dollfus C, Trocme N, Tabone MD, Vaudre G, Courpotin C, Leverger G.

Arch Pediatr. 2010 Jun;17(6):945-6. doi: 10.1016/S0929-693X(10)70191-3. French. No abstract available.

PMID:
20654973
12.

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.

Delaugerre C, Chaix ML, Blanche S, Warszawski J, Cornet D, Dollfus C, Schneider V, Burgard M, Faye A, Mandelbrot L, Tubiana R, Rouzioux C; ANRS French Perinatal Cohort.

Retrovirology. 2009 Sep 19;6:85. doi: 10.1186/1742-4690-6-85.

13.

Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors.

Benhammou V, Warszawski J, Bellec S, Doz F, André N, Lacour B, Levine M, Bavoux F, Tubiana R, Mandelbrot L, Clavel J, Blanche S; ANRS-Enquête Périnatale Française.

AIDS. 2008 Oct 18;22(16):2165-77. doi: 10.1097/QAD.0b013e328311d18b. Erratum in: AIDS. 2012 May 15;26(8):1047. Carbillon, François F [corrected to Carbillon, L].

PMID:
18832880
14.

High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.

Durand-Gasselin L, Pruvost A, Dehée A, Vaudre G, Tabone MD, Grassi J, Leverger G, Garbarg-Chenon A, Bénech H, Dollfus C.

Antimicrob Agents Chemother. 2008 Jul;52(7):2555-63. doi: 10.1128/AAC.01130-07. Epub 2008 Apr 21.

15.

[Psychosocial issues in HIV positive women during the perinatal period].

Diagne Gueye NR, Dollfus C, Tabone MD, Hervé F, Courcoux MF, Vaudre G, Trocmé N, Leverger G.

Arch Pediatr. 2007 May;14(5):461-6. Epub 2007 Feb 15. French.

PMID:
17306514
16.

[Long term outcomes in HIV infected adolescents followed from birth].

Dollfus C, Tabone MD, Trocme N, Vaudre G, Leverger G.

Med Mal Infect. 2006 Sep;36(9):479-80. Epub 2006 Oct 2. French. No abstract available.

PMID:
17011735
17.

[Living after an acute lymphoblastic leukemia].

Vaudre G, Parker JL, Leverger G.

Soins Pediatr Pueric. 2006 Jun;(230):41-4. French. No abstract available.

PMID:
16884120
18.

[How to discuss death with a dying child: a story can help?].

Auvrignon A, Fasola S, Loedec C, Aumont C, Nomdedeu S, Landman-Parker J, Gervaise S, Vaudre G, Renolleau S, Leverger G.

Arch Pediatr. 2006 May;13(5):488-500. Epub 2006 Apr 17. French.

PMID:
16616464
19.

[Quality of life of adolescents surviving childhood acute lymphoblastic leukemia].

Vaudre G, Trocmé N, Landman-Parker J, Maout F, Tabone MD, Tourniaire B, Gouraud F, Dollfus C, Auvrignon A, Leverger G.

Arch Pediatr. 2005 Nov;12(11):1591-9. Epub 2005 Oct 10. French.

PMID:
16216482
20.

[HIV mother to child transmission: improvement and future].

Tabone MD, Vaudre G, Dehée A, Dollfus C.

Arch Pediatr. 2005 Jan;12(1):1-3. French. No abstract available.

PMID:
15653046
Items per page

Supplemental Content

Loading ...
Write to the Help Desk